Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-05-17
2011-05-17
Russel, Jeffrey E (Department: 1654)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S093710, C424S277100, C435S372000, C514S019300, C514S021400, C514S021500, C514S021600, C530S326000, C530S327000, C530S328000
Reexamination Certificate
active
07943138
ABSTRACT:
Provided are compositions and methods for treating survivin expressing cancers. The compositions contain peptide survivin peptide mimics with improved MHC-I binding characteristics. The method involves administering a survivin peptide mimic with improved MHC-I binding characteristics to an individual to effect inhibition of the growth of survivin expressing cancer cells in the individual.
REFERENCES:
patent: 2004/0176573 (2004-09-01), Thor et al.
patent: 2006/0073159 (2006-04-01), Vonderheide et al.
patent: 2007/0083334 (2007-04-01), Mintz et al.
patent: 2007/0104689 (2007-05-01), Gillies et al.
Ciesielski Michael J.
Fenstermaker Robert A.
Health Research , Inc.
Hodgson & Russ LLP
Russel Jeffrey E
LandOfFree
Survivin peptides as cancer vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Survivin peptides as cancer vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Survivin peptides as cancer vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2654547